| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 32 |
| 1 | METHOTREXATE SODIUM | 28 |
| 2 | METHOTREXATE | 27 |
| 3 | ALBUTEROL SULFATE | 26 |
| 4 | ASPIRIN | 26 |
| 5 | ASPIRIN 325 MG | 25 |
| 6 | ASPIRIN 81 MG | 25 |
| 7 | ADALIMUMAB | 24 |
| 8 | ALPRAZOLAM | 24 |
| 9 | PREGABALIN | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EMAPALUMAB-LZSG | 3 | 0.0127 |
| 1 | METYROSINE | 1 | 0.0123 |
| 2 | DERMATOPHAGOIDES FARINAE | 1 | 0.0120 |
| 3 | EUCALYPTOL, MENTHOL, UNSPECIFIED FORM, METHYL SALICYLATE, AND THYMOL | 1 | 0.0045 |
| 4 | NALBUPHINE HYDROCHLORIDE | 1 | 0.0044 |
| 5 | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | 1 | 0.0030 |
| 6 | IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 10% | 1 | 0.0026 |
| 7 | PURIXAN | 2 | 0.0026 |
| 8 | PSYLLIUM HUSK | 2 | 0.0015 |
| 9 | VALERIAN | 1 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 80 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 65 |
| 2 | Benzodiazepine [EPC] | 45 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 35 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 28 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 28 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 27 |
| 7 | Mood Stabilizer [EPC] | 25 |
| 8 | Anti-IgE [EPC] | 19 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 19 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interferon gamma Blocker [EPC] | 3 | 0.0127 |
| 1 | Catecholamine Synthesis Inhibitor [EPC] | 1 | 0.0123 |
| 2 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 14 | 0.0024 |
| 4 | Methylating Agent [EPC] | 1 | 0.0010 |
| 5 | Provitamin D2 Compound [EPC] | 18 | 0.0006 |
| 6 | Carnitine Analog [EPC] | 2 | 0.0005 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 8 | Interleukin-17A Antagonist [EPC] | 15 | 0.0004 |
| 9 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 8 | 0.0004 |